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Abstract 
Review on AFAP1L2, with data on DNA/RNA, on 
the protein encoded and where the gene is 
implicated. 
 
 
Identity 
Other names: KIAA1914, XB130 
HGNC (Hugo): AFAP1L2 
Location: 10q25.3 
 
 
Figure 1. XB130 chromosomal location and neighbour genes. A. xb130 gene is located on chromosome 10, at 10q25.3 by 
fluorescence in situ hybridization (FISH). B. Diagram of xb130 neighbour genes between 115939029 and 116450393. 
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Figure 2. XB130 functional domains and motifs. Human XB130 has 818 amino acids. It contains the following motif/domains: 
proline-rich region: residues 98-107; tyrosine phosphorylation motif: residues 54-57, 124-127; 148-151; 457-460; PH domain: 
residues 175-272; 353-445; coiled-coil region: residues 652-749. 
 
 
DNA/RNA 
Note 
Human XB130 was discovered in Dr. Mingyao 
Liu's laboratory (University of Toronto) in the 
process of cloning human actin filament associated 
protein (afap) gene. Using chicken AFAP protein 
sequence to search human cDNA library in 
GenBank, XB130 was found as an EST clone 
(GenBank accession number 1154093) with 34% 
sequence similarity to chicken AFAP protein. The 
clone contains partial coding sequence and 3' UTR. 
The upstream sequence was obtained using 5' rapid 
amplification of cDNA ends (RACE) from human 
lung alveolar epithelial cell mRNA. Western blot 
shows the protein molecular weight is 130 kD (Xu 
et al., 2007).  
In 2003, the XB130 knockout mice were 
established through the collaboration of Drs. 
Mingyao Liu and Tak W. Mak at the University of 
Toronto. 
Description 
Human xb130 genes contains 19 exons, which are 
covering the whole coding sequence. 
Transcription 
The transcript size of xb130 is 3751 bp. There may 
be 7 splicing variants based on Ensembl data 
(www.ensembl.org). XB130 mRNA is highly 
expressed in the thyroid, parathyroid and spleen; 
moderately expressed in brain, pancreas, lung and 
kidney. 
Protein 
Description 
XB130 is a novel adaptor protein, member of the 
actin filament associated protein (AFAP) family 
(Snyder et al., 2011). Accordingly, it is also known 
as AFAP1L2. The full length protein consists of 
818 amino acids with a molecular weight of 
approximately 130 kDa by western blotting (Xu et 
al., 2007). As an adaptor protein, XB130 has no 
enzymatic domains or activity. Sequence structure 
analysis has revealed 23 putative tyrosine 
phosphorylation sites and 27 putative 
phosphorylation sites for serine/threonine kinases 
(Xu et al., 2007). The N-terminal of XB130 
contains a proline rich, SH3 domain binding motif, 
three tyrosine containing SH2 domain binding sites 
(Xu et al., 2007), of which a YXXM motif is for 
PI3 kinase subunit p85 binding (Lodyga et al., 
2009). In the middle region, there are two pleckstrin 
homology domains and another tyrosine binding 
motif (Xu et al., 2007). The C-terminal contains a 
coiled-coil region, which may be important for 
molecular trafficking or dimerization (Xu et al., 
2007). 
Expression 
In normal human tissue, the 4 kb mRNA transcript 
of XB130 is expressed highly in spleen and thyroid 
with lower expression in kidney, brain, lung and 
pancreas (Xu et al., 2007).  
Newer RNA sequencing by Illumina body map 
using RNA obtained from 16 normal human tissues 
shows high expression of XB130 in thyroid with 
lower expression in lymph nodes, brain, colon, 
adipocytes, kidney, lung, adrenal glands, breast, 
ovary, prostate and testis followed by whole blood, 
heart, skeletal muscles and liver 
(www.genecards.org). 
XB130 protein is detected in normal tissues of 
thyroid, parathyroid, brain, kidney, skin and GI-
tracks (www.proteinatlas.org). 
XB130 protein expresses in human thyroid, 
colorectal, gastric and hepatocellular carcinomas 
(Shi et al., 2012; Shiozaki et al., 2013; Shiozaki et 
al., 2011; Zuo et al., 2012). Expression of XB130 
has also been observed in a variety of cancer cell 
lines, including thyroid, lung, esophageal, 
pancreatic and colon cancers (Shi et al., 2012; 
Shiozaki et al., 2013; Zuo et al., 2012). 
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Localisation 
XB130 is distributed mainly in the cytoplasm and 
perinuclear region of lung epithelial BEAS-2B cells 
and several other cell types (Xu et al., 2007). 
Unlike AFAP, XB130 does not associate or co-
localize with actin filament stress fibler (Lodyga et 
al., 2010).  
Stimulation of cells with EGF, PMA, or 
overexpression of constitutive Rac results in a 
translocation of XB130 to the cell periphery and 
leading edge of migrating cells (Lodyga et al., 
2010). 
Function 
XB130 is an adaptor protein that acts as a key 
mediator to drive signal transduction pathways. 
XB130 has been shown to bind to tyrosine kinase c-
Src to enhance kinase activity and subsequently 
regulates Src-mediated AP-1/SRE transcription 
activation (Xu et al., 2007).  
XB130 is also highly involved in the PI3K/Akt 
pathway and effects cell proliferation, cell cycle 
progression and cell survival through binding to 
p85 alpha subunit of PI3K (Lodyga et al., 2009). 
XB130 may also play a role in the innate immune 
response, where knockdown of XB130 was shown 
to decrease IL-6 and IL-8 cytokine levels in human 
lung epithelial cells (Xu et al., 2007). XB130 is also 
involved in cell migration via association with Rac-
GTPase and plays a significant role in lateral cell 
migration and cell invasion in both normal and 
cancer cell lines (Lodyga et al., 2010). 
Yamanaka et al. reported phosphorylated XB130 
affects cAMP-dependent DNA synthesis in rat 
thyroid cells (Yamanaka et al., 2012). XB130 is 
aberrantly expressed in human cancers and has been 
shown to control tumour growth in vivo (Shiozaki 
et al., 2011).  
XB130 regulates thyroid cancer cell proliferation 
by controlling microRNA miR-33a, 149a and 193a 
expression to alter oncogenes Myc, FosL1, and 
SCL7A5 protein levels (Takeshita et al., 2013). 
Homology 
XB130 shares similar sequence and domain 
structure cellular as AFAP and AFAP1L1 (Snyder 
et al., 2011). 
Mutations 
Somatic 
Somatic mutations of XB130 are reported in a 
variety of cancer tissues.  
Based on the data of Sanger Institute database 
(www.sanger.ac.uk), XB130 mutation sites have 
been identified in multiple tumor tissues, including  
 
 
lung, large intestine, ovary, skin, prostate, 
endometrium.  
Among these samples, 70% of identified cases are 
XB130 substitution missense mutation. 
Implicated in 
Various cancers 
Note 
XB130 plays important roles in tumor progression 
by promoting cell proliferation, survival, motility 
and invasion in various cancer cells.  
Recently, XB130 has been identified in thyroid 
carcinoma (Shiozaki et al., 2011), esophageal 
squamous cell carcinoma (Shiozaki et al., 2013), 
and gastric cancer (Shi et al., 2012). 
Colorectal cancer 
Note 
Tyrosine phosphorylated XB130 in colorectal 
cancer. 
Prognosis 
Using mass spectrometry, Emaduddin et al. 
reported several proteins as tyrosine phosphorylated 
form are maintained at high level in colorectal 
cancer cells isolated from patients.  
XB130 is identified as one of these proteins. 
Therefore, tyrosine phosphorylated XB130 has a 
potential to be a biomarker of colorectal cancer 
(Emaduddin et al., 2008). 
Gastric cancer (GC) 
Note 
XB130 expression level associates with the 
prognosis of gastric cancer. 
Prognosis 
Based on the anlysis GC tissue samples from 411 
patients with various stages, lower expression of 
XB130 mRNA as well as protein is significantly 
correlated with reduced patient survival time and 
shorter disease-free period (Shi et al., 2012). 
Thyroid cancer 
Note 
XB130 as a tumor promoting gene, enhancing 
thyroid cancer cell growth. 
Oncogenesis 
Knockdown XB130 using siRNA in thyroid cancer 
cell (WRO) is accompanied with an inhibition of 
G1-S phase cell cycle progression and enhanced 
apoptosis.  
The volume of tumors generated in nude mice after 
injecting these cells are smaller than those formed 
from cells with a normal XB130 expression 
(Shiozaki et al., 2011). 
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Esophageal squamous cell 
carcinoma (ESCC) 
Note 
XB130 protein is identified in ESCC primary cell 
lines and tumor samples. 
Oncogenesis 
XB130 protein is highly expression in ESCC 
primary cells. XB130 protein is examined by 
immunohistochemistry staining from ESCC tissues 
collected from 52 patients. Positive XB130 staining 
is observed in 71% of ESCC samples, which 
indicates the association of XB130 protein and 
ESCC (Shiozaki et al., 2013). 
Soft tissue tumor 
Note 
Decreased XB130 expression leads to a local 
aggressiveness of soft tissue tumor. 
Oncogenesis 
Analysis of gene expression profile of 102 tumor 
samples with varying stages of soft tissue tumor 
shows a decreased XB130 expression in malignant 
mesenchymal tumors (Cunha et al., 2010). 
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